Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04116294
Other study ID # 2018-02142
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2019
Est. completion date April 30, 2020

Study information

Verified date November 2019
Source University Hospital, Geneva
Contact Christophe Christophe, MD
Phone +15149435717
Email Christophe.Fehlmann@hcuge.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to assess whether a computer-assisted prescription allows a reduction of the overall number of inappropriate PAR in emergency departments.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date April 30, 2020
Est. primary completion date April 30, 2020
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria:

- Patients aged 16 or more with a PAR.

Exclusion Criteria:

- Refusal to participate

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Computer-assisted prescription
The intervention is based on a computer-assisted prescription: when a PAR will be ordered, an alert will arise and explain the recognized indications for this examination and ask a confirmation for the prescription. This is a non-blocking system: physicians will be able to prescribe PAR even if the PAR is not appropriate.

Locations

Country Name City State
Switzerland Hôpitaux Universitaires de Geneve Geneve
Switzerland Hôpital de La Tour Meyrin

Sponsors (1)

Lead Sponsor Collaborator
Christophe Fehlmann

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of plain abdominal radiopraphy (PAR) with an inappropriate indication 4 indications are considered as appropriate : (1) foreign body suspicion, (2) checking after contrast injection, (3) catheter checking and (4) follow-up of urolithiasis. Order for PAR will be independantly reviewed by blinded assessors. Same ED consultation (or max 24 hours)
Secondary Incidence of additional radiological examination (CT, US, IRM) after the PAR Same ED consultation (or max 24 hours)